RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
DiaSorin SpA Stock

DiaSorin SpA P/E 2024

DiaSorin SpA P/E

29.51

Ticker

DIA.MI

ISIN

IT0003492391

WKN

A0MTB2

As of Sep 10, 2024, DiaSorin SpA's P/E ratio was 29.51, a -13.76% change from the 34.22 P/E ratio recorded in the previous year.

The DiaSorin SpA P/E history

DiaSorin SpA Aktienanalyse

What does DiaSorin SpA do?

DiaSorin SpA is an Italian medical technology company that specializes in the development and production of diagnostic solutions for serious diseases. The company was founded in 1968 in Saluggia, a small town in the Piedmont region of northern Italy. Since then, DiaSorin has experienced impressive growth and now operates worldwide. DiaSorin is a major player in the in-vitro diagnostics (IVD) market and offers a wide range of solutions for clinical laboratories and medical professionals. The company's business model is based on the development of innovative test systems that enable fast, reliable, and accurate diagnosis of diseases. The company's goal is to provide improved access to diagnostic opportunities for patients worldwide and support the entire medical practice. In its early days, DiaSorin mainly focused on the development and production of enzyme immunoassays (EIAs) and other immunochemical tests. However, over the years, the company has evolved and introduced a variety of product lines, including molecular diagnostic tests, automated immunoassay systems and instruments, and clinical laboratory software. Today, DiaSorin has four main business areas: Immunoassays, Molecular Biology, Automation, and Diagnosis Information Management. The Immunoassays business area, also known as diaMune, offers a wide range of immunoassay solutions based on various technologies, including chemiluminescence, ELISA, fluorescence, and multiplexing. The Molecular Biology business area, also known as DiaMolecular, develops and produces a broad spectrum of molecular diagnostic solutions, including tests for infectious diseases, oncological diseases, and genetic disorders. DiaMolecular's products provide fast, efficient, and highly accurate diagnosis of serious diseases, enabling early treatment and therapy. The third major business area, DiaSorin's automation solutions, offers instruments and automated testing systems that optimize laboratory processes, improve efficiency, and speed up test execution. These solutions not only increase the accuracy and reliability of diagnostic tests but also help reduce costs and workload in medical laboratories. Finally, DiaSorin's Diagnosis Information Management business area offers a variety of software solutions that assist medical professionals in managing and interpreting diagnostic data. These solutions enable faster and more accurate diagnosis and can also contribute to improving patient care and optimizing laboratory processes. DiaSorin is led by a strong and experienced management team committed to driving the company's growth through continuous innovation and expansion into new markets. With branches and subsidiaries around the world, DiaSorin is a key player in the global medical technology industry. Overall, DiaSorin is an innovative and forward-thinking company that continuously develops its technologies and solutions to improve the quality of life for millions of people worldwide. DiaSorin SpA ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering DiaSorin SpA's P/E Ratio

The Price to Earnings (P/E) Ratio of DiaSorin SpA is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing DiaSorin SpA's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of DiaSorin SpA is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in DiaSorin SpA’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about DiaSorin SpA stock

What is the price-to-earnings ratio of DiaSorin SpA?

The price-earnings ratio of DiaSorin SpA is currently 29.51.

How has the price-earnings ratio of DiaSorin SpA changed compared to last year?

The price-to-earnings ratio of DiaSorin SpA has increased by -13.76% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of DiaSorin SpA high compared to other companies?

Yes, the price-to-earnings ratio of DiaSorin SpA is high compared to other companies.

How does an increase in the price-earnings ratio of DiaSorin SpA affect the company?

An increase in the price-earnings ratio of DiaSorin SpA would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of DiaSorin SpA affect the company?

A decrease in the price-earnings ratio of DiaSorin SpA would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of DiaSorin SpA?

Some factors that influence the price-earnings ratio of DiaSorin SpA are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does DiaSorin SpA pay?

Over the past 12 months, DiaSorin SpA paid a dividend of 1.1 EUR . This corresponds to a dividend yield of about 1.07 %. For the coming 12 months, DiaSorin SpA is expected to pay a dividend of 1.24 EUR.

What is the dividend yield of DiaSorin SpA?

The current dividend yield of DiaSorin SpA is 1.07 %.

When does DiaSorin SpA pay dividends?

DiaSorin SpA pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of DiaSorin SpA?

DiaSorin SpA paid dividends every year for the past 0 years.

What is the dividend of DiaSorin SpA?

For the upcoming 12 months, dividends amounting to 1.24 EUR are expected. This corresponds to a dividend yield of 1.2 %.

In which sector is DiaSorin SpA located?

DiaSorin SpA is assigned to the 'Health' sector.

Wann musste ich die Aktien von DiaSorin SpA kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of DiaSorin SpA from 5/22/2024 amounting to 1.15 EUR, you needed to have the stock in your portfolio before the ex-date on 5/20/2024.

When did DiaSorin SpA pay the last dividend?

The last dividend was paid out on 5/22/2024.

What was the dividend of DiaSorin SpA in the year 2023?

In the year 2023, DiaSorin SpA distributed 1.05 EUR as dividends.

In which currency does DiaSorin SpA pay out the dividend?

The dividends of DiaSorin SpA are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von DiaSorin SpA

Our stock analysis for DiaSorin SpA Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DiaSorin SpA Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.